Stock DUL ALNYLAM PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Alnylam Pharmaceuticals, Inc. BOERSE MUENCHEN

Equities

DUL

US02043Q1076

Real-time BOERSE MUENCHEN
Other stock markets
 04:13:07 2024-07-09 am EDT 		5-day change 1st Jan Change
237.6 EUR +1.06% Intraday chart for Alnylam Pharmaceuticals, Inc. +3.11% +32.82%
Jul. 03 Jerome Powell did it again Our Logo
Jul. 03 JPMorgan Chase Raises Price Target on Alnylam Pharmaceuticals to $248 From $160 MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. ALNY Stock
  4. DUL Stock
  5. Revisions Alnylam Pharmaceuticals, Inc.